Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04621695
Other study ID # NL69227.018.19
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 25, 2019
Est. completion date November 25, 2023

Study information

Verified date March 2021
Source Proctos Kliniek
Contact Lisette Dekker, MD
Phone +31612204316
Email l.dekker@proctoskliniek.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rationale: Haemorrhoidal disease is one of the most common anorectal disorders which affects nearly half of the general population1. Given the current numerous modalities the obvious question which needs to be answered is which treatment is the best. An interesting conclusion from a recent systematic review regarding operative procedures for haemorrhoidal disease is that all procedures have their own advantages and disadvantages. There is a need for evaluating treatment from the patient's point of view and transparency in surgical and non-surgical treatment outcome. So far there is no sufficiently large trial that meets that demand. Objective: To establish the best treatment of patients with symptomatic haemorrhoids grade III: haemorrhoidectomy versus rubber band ligation (RBL). Patient bound effectiveness, clinical effectiveness and cost-utility of both treatments is compared; primary outcome is quality of life at 24 months measured with the EQ-5D-5L with Dutch rating and recurrence at one year post procedure. The assumption is that treatment with rubber band ligation is equally effective in comparison with haemorrhoidectomy in terms of quality of life. Study design:Multicentre randomized controlled non-inferiority trial with cost-utility analysis. Two treatment protocols are compared: haemorrhoidectomy and rubber band ligation. Study population: Patients aged ≥ 18 years with symptomatic haemorrhoids gr III. Patients are recruited in multiple clinics during 18-24 months. Intervention: Participants are allocated to either rubber band ligation or haemorrhoidectomy. Main study parameters/endpoints: Primary outcome measure is quality of life at 24 months measured with the EQ-5D-5L with Dutch rating and recurrence at one year post procedure. Secondary outcomes are: complaint reduction with proctology specific patient-related outcome measure (HSS, PROM, PROMHISS), vaizey score, resumption of work, pain (VAS), complications and recurrence at two years.


Recruitment information / eligibility

Status Recruiting
Enrollment 360
Est. completion date November 25, 2023
Est. primary completion date November 25, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Haemorrhoids grade III (Goligher classification) - Age 18 years and older - Sufficient understanding of the Dutch written language (reading and writing) Exclusion Criteria: - Previous rectal or anal surgery with the exception of rubber band ligation - Previous surgery for haemorrhoids (at any time) - More than one injection treatment for haemorrhoids in the past 3 years - More than one rubber band ligation procedure in the past 3 years - Previous rectal radiation - Pre-existing sphincter injury - Inflammatory bowel disease - Medically unfit for surgery or for completion of the trial (ASA>III) - Pregnancy - Hyper-coagulability disorders - Patients previously randomised to this trial - Not able or willing to provide written informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
RBL
Both arms are standard care procedures in the Netherlands
Hemorrhoidectomy
Both arms are standard care procedures in the Netherlands

Locations

Country Name City State
Netherlands Flevoziekenhuis Almere
Netherlands Meander MC Amersfoort
Netherlands OLVG Amsterdam
Netherlands University Medical Center location AMC Amsterdam
Netherlands IJsselland ziekenhuis Capelle Aan Den IJssel
Netherlands Groene Hart ziekenhuis Gouda
Netherlands MUMC+ Maastricht
Netherlands Centraal Militair Hospitaal Utrecht
Netherlands Diakonessenhuis Utrecht

Sponsors (1)

Lead Sponsor Collaborator
Proctos Kliniek

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Health related quality of life The EQ-5D-5L is a generic Health Related Quality of Life (HRQoL) measure, which is broadly used in economic evaluation. The instrument examines a patient's HRQoL on the day of the interview. It consists of the EQ-5D-5L descriptive system and the EQ-Visual Analogue Scale. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has five levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses to the 5 items result in a patient's health state that can be transformed into an index score representing health-related quality of life, ranging between 0 (death) and 1 (full health). These index scores are combined with length of life to calculate the QALY. The EQ-VAS records the patient's self-rated health with endpoints labelled 'the best health you can imagine' at the top and 'the worst health you can imagine' at the bottom. 24 months
Primary Recurrence Patient self reported assessment with a dichotomous question: "At the moment, do you feel your symptoms from your haemorrhoids are: (1) cured or improved compared with before treatment; or (2) unchanged or worse compared with before treatment?" Any patient who answers '1' but has required further treatment since the initial procedure will be reclassified as '2', identified via hospital records, their consultant and patient questioning at 12 months
Primary In-hospital direct costs with EQ-5D-5L and cost incremental analysis (iMCQ and iPCQ): The impact of disease on the ability of a person to perform work should be part of an economic evaluation when a societal perspective is applied. iMTA is highly experienced in methods for measuring and valuing productivity losses.The Productivity Costs Questionnaire (iPCQ) may be combined with the iMTA Medical Consumption Questionnaire (iMCQ), a generic instrument for measuring medical costs. The iMCQ includes questions related to frequently occurring contacts with health care providers and can be complemented with extra questions that are relevant for specific study populations. this will be asked at 6 weeks, 6, 12 and 24 months
Primary In-hospital indirect costs with EQ-5D-5L and cost incremental analysis (iMCQ and iPCQ): The impact of disease on the ability of a person to perform work should be part of an economic evaluation when a societal perspective is applied. iMTA is highly experienced in methods for measuring and valuing productivity losses.The Productivity Costs Questionnaire (iPCQ) may be combined with the iMTA Medical Consumption Questionnaire (iMCQ), a generic instrument for measuring medical costs. The iMCQ includes questions related to frequently occurring contacts with health care providers and can be complemented with extra questions that are relevant for specific study populations. this will be asked at 6 weeks, 6, 12 and 24 months
Primary Out-of-hospital postoperative costs with EQ-5D-5L and cost incremental analysis (iMCQ and iPCQ): The impact of disease on the ability of a person to perform work should be part of an economic evaluation when a societal perspective is applied. iMTA is highly experienced in methods for measuring and valuing productivity losses.The Productivity Costs Questionnaire (iPCQ) may be combined with the iMTA Medical Consumption Questionnaire (iMCQ), a generic instrument for measuring medical costs. The iMCQ includes questions related to frequently occurring contacts with health care providers and can be complemented with extra questions that are relevant for specific study populations. this will be asked at 6 weeks, 6, 12 and 24 months
Secondary Health related quality of life The EQ-5D-5L is a generic Health Related Quality of Life (HRQoL) measure, which is broadly used in economic evaluation. The instrument examines a patient's HRQoL on the day of the interview. It consists of the EQ-5D-5L descriptive system and the EQ-Visual Analogue Scale. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has five levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Responses to the 5 items result in a patient's health state that can be transformed into an index score representing health-related quality of life, ranging between 0 (death) and 1 (full health). These index scores are combined with length of life to calculate the QALY. The EQ-VAS records the patient's self-rated health with endpoints labelled 'the best health you can imagine' at the top and 'the worst health you can imagine' at the bottom. 12 months
Secondary Patient reported outcome measures concerning symptoms in daily life; Vaizey score Vaizey faecal continence score consists of 7 questions with a maximum of score of 24. The higher the score, the higher the worse the outcome. 12 months
Secondary Patient reported outcome measures concerning symptoms in daily life; proctoPROM The proctoPROM is a validated questionnaire consisting of five questions concerning patients well-being, wich are each scored on a numeric rating scale from 0 to 10. Regarding impact of symptoms, 0 correlates with 'no impact at all' and 10 with 'highly impacted on daily life'. Than the mean of the 5 question is taken. 12 months
Secondary Patient reported outcome measures concerning symptoms in daily life; PROM-HISS Patient-Reported Outcome Measure-Haemorrhoidal Impact and Satisfaction Score which are each scored on a numeric rating scale from 0 to 10. Regarding impact of symptoms, 0 correlates with 'no impact at all' and 10 with 'highly impacted on daily life'. For patient satisfaction with treatment, this ranges between 0 'not satisfied' and 10 'very satisfied'. 12 months
Secondary Patient reported outcome measures concerning symptoms in daily life; HHS Hemorrhoid severity score consists of five questions concerning the frequency of symptoms of hemorrhoids. The higher the score the more frequent the symptoms occur. 12 months
Secondary Patient reported outcome measures concerning symptoms in daily life, VAS pain score The pain visual analogue scale has a numeric rating scale from 0 to 10 with 0 being 'no pain' and 10 'worse pain you ever felt'. this will be asked 1 day post procedure, 1 week and 6 weeks post procedure.
Secondary Return to work Number of days patients are able to return to work this will be asked at 1 week and 6 weeks post procedure.
Secondary Need for further treatment 12 months
Secondary Complications Adverse events as: peroperative bleeding, postoperative bleeding, urinary retention requiring catheterisation, pelvic sepsis, anal fissure, anal fistula, wound discharge, residual anal skintages, anal stenosis, fecal incontinence, death 12 months
See also
  Status Clinical Trial Phase
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Withdrawn NCT02851940 - Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids N/A
Recruiting NCT02301052 - Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms Phase 1/Phase 2
Completed NCT02216305 - HAL-RAR Versus Hemorrhoidectomy in the Treatment of Grade III-IV Hemorrhoids. Prospective, Randomized Trial N/A
Completed NCT02358174 - Hemorrhoids and Metalloproteinases, Observational Study N/A
Completed NCT01483833 - Efficacy Study of Iferanserin to Treat Hemorrhoids Phase 2
Completed NCT00397137 - Stapled Anopexy Versus Closed Haemorrhoidectomy for Haemorrhoids N/A
Completed NCT00841620 - Symptom Control 1-year After Circular Stapler Anopexy or Diathermy Excision for Prolapsed Haemorhoids Phase 4
Completed NCT06459739 - Effect of Sacral Erector Spinae Plane Block on Hemorrhoid and Pilonidal Sinus Surgery N/A
Completed NCT04276298 - Topical Analgesia Post-Haemorrhoidectomy Phase 2/Phase 3
Completed NCT04675177 - Polidocanol Foam VS Artery Ligation in Hemorrhoidal Disease Phase 2/Phase 3
Recruiting NCT05889962 - Ultrasound-guided Pudendal Nerve Block for Pain After Hemorrhoidectomy N/A
Recruiting NCT01961739 - Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids Phase 2/Phase 3
Active, not recruiting NCT02061176 - THD Versus Open Haemorrhoidectomy N/A
Withdrawn NCT00512044 - Local Versus General Anaesthesia in Stapled Hemorrhoidectomy Phase 4
Completed NCT04031131 - The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids Phase 2
Recruiting NCT04329364 - RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty Phase 2/Phase 3
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Completed NCT04567485 - Impact of Moderate to Severe Pain in the Post-intervention Monitoring Room After Hemorrhoidectomy on the Length of Stay in the Outpatient Surgery Unit
Completed NCT03298997 - Ligation and Hemorrhoidopexy Technique Versus Ligation of Hemorrhoidal Arteries Using Ultrasound for Hemorrhoids N/A